... <a href= MedMen Q4 Revenue Expected To Grow 40% to $29.9 Million " />

Australis Capital Inc. (CSE: AUSA) is pleased to announce the Company has invested $3,000,000 USD in Folium Biosciences, the largest vertically integrated producer, manufacturer, and distributor of hemp derived phytocannabinoids in the United States.

MedMen Q4 Revenue Expected To Grow 40% to $29.9 Million " data-title="Tweet">
MedMen Q4 Revenue Expected To Grow 40% to $29.9 Million " data-title="Share">
MedMen Q4 Revenue Expected To Grow 40% to $29.9 Million " data-title="Pin">
MedMen Q4 Revenue Expected To Grow 40% to $29.9 Million " data-title="Share">
MedMen Q4 Revenue Expected To Grow 40% to $29.9 Million " data-title="+1">
MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.




( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )